ABIONYX Pharma Yönetim
Yönetim kriter kontrolleri 4/4
ABIONYX Pharma's CEO is Cyrille Tupin, appointed in Sep 2019, has a tenure of 5.17 years. total yearly compensation is €278.85K, comprised of 79.1% salary and 20.9% bonuses, including company stock and options. directly owns 4.59% of the company’s shares, worth €2.00M. The average tenure of the management team and the board of directors is 5.2 years and 8.5 years respectively.
Anahtar bilgiler
Cyrille Tupin
İcra Kurulu Başkanı
€278.8k
Toplam tazminat
| CEO maaş yüzdesi | 79.1% |
| CEO görev süresi | 5.2yrs |
| CEO sahipliği | 4.6% |
| Yönetim ortalama görev süresi | 5.2yrs |
| Yönetim Kurulu ortalama görev süresi | 8.5yrs |
CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -€3m |
| Mar 31 2024 | n/a | n/a | -€3m |
| Dec 31 2023 | €279k | €221k | -€4m |
| Sep 30 2023 | n/a | n/a | -€4m |
| Jun 30 2023 | n/a | n/a | -€4m |
| Mar 31 2023 | n/a | n/a | -€4m |
| Dec 31 2022 | €289k | €210k | -€4m |
| Sep 30 2022 | n/a | n/a | -€5m |
| Jun 30 2022 | n/a | n/a | -€6m |
| Mar 31 2022 | n/a | n/a | -€6m |
| Dec 31 2021 | €649k | €200k | -€6m |
| Sep 30 2021 | n/a | n/a | -€5m |
| Jun 30 2021 | n/a | n/a | -€4m |
| Mar 31 2021 | n/a | n/a | -€3m |
| Dec 31 2020 | €711k | €200k | -€2m |
| Sep 30 2020 | n/a | n/a | -€2m |
| Jun 30 2020 | n/a | n/a | -€2m |
| Mar 31 2020 | n/a | n/a | -€59k |
| Dec 31 2019 | n/a | n/a | €2m |
| Sep 30 2019 | n/a | n/a | €925k |
| Jun 30 2019 | n/a | n/a | €1k |
| Mar 31 2019 | n/a | n/a | -€3m |
| Dec 31 2018 | €5m | €175k | -€6m |
Tazminat ve Piyasa: Cyrille's total compensation ($USD304.29K) is about average for companies of similar size in the French market ($USD326.18K).
Tazminat ve Kazançlar: Cyrille's compensation has been consistent with company performance over the past year.
CEO
Cyrille Tupin (48 yo)
5.2yrs
Görev süresi
€278,848
Tazminat
Sir Cyrille Tupin, CPA is Chief Executive Officer, General Manager and Director at ABIONYX Pharma SA since September 6, 2019. Mr. Tupin served as the Chief Financial and Administrative Officer at ABIONYX...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO, GM & Director | 5.2yrs | €278.85k | 4.59% € 2.0m | |
| Independent Director | 5.8yrs | €29.25k | Veri yok | |
| Administrative & Financial Director | no data | Veri yok | Veri yok | |
| Vice President of Clinical | no data | Veri yok | Veri yok | |
| Chief Medical Officer and Head of R&D | less than a year | Veri yok | Veri yok | |
| Chief Digital & Innovation Officer | no data | Veri yok | Veri yok |
5.2yrs
Ortalama Görev Süresi
67yo
Ortalama Yaş
Deneyimli Yönetim: ABNX's management team is seasoned and experienced (5.2 years average tenure).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO, GM & Director | 5.2yrs | €278.85k | 4.59% € 2.0m | |
| Independent Director | 9.8yrs | €29.25k | Veri yok | |
| Censor | 9.8yrs | Veri yok | Veri yok | |
| Chairman of Scientific Advisory Board | no data | €23.00k | Veri yok | |
| Independent Director | 7.4yrs | €29.25k | Veri yok | |
| Independent Director | 9.5yrs | €18.75k | Veri yok | |
| Chairman of the Board | 5.3yrs | €22.05k | 12.54% € 5.5m |
8.5yrs
Ortalama Görev Süresi
54yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: ABNX's board of directors are considered experienced (8.5 years average tenure).